ImmunoGen, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q3 2010 to Q3 2023
-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
ImmunoGen, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q3 2010 to Q3 2023.
- ImmunoGen, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2023 was 288M shares, a 13.4% increase year-over-year.
- ImmunoGen, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 254M shares, a 23% increase from 2021.
- ImmunoGen, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 206M shares, a 17% increase from 2020.
- ImmunoGen, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2020 was 176M shares, a 18.8% increase from 2019.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)